IBM kicked off 2026 with a textbook “beat and raise” quarter, yet the market response was anything but textbook. Shares in the technology giant slid as much as 10 percent on Thursday following the earnings release, closing the week at €193.88 in Frankfurt — a decline of roughly 9 percent over seven days. The disconnect between strong headline numbers and investor sentiment underscores a growing unease about where the company’s growth is actually coming from.
Revenue for the first quarter climbed 9.5 percent to $15.9 billion, comfortably ahead of analyst forecasts. Adjusted earnings per share of $1.91 beat consensus by 10 cents. Free cash flow jumped 13 percent to $2.2 billion, marking the strongest start to a fiscal year in a decade, driven by an operating margin expansion of 140 basis points. Yet the stock now sits only narrowly above its 52-week low from February, having shed roughly 22 percent since the start of the year and trading nearly 29 percent below its 52-week high.
Infrastructure Surge
The standout performer was the infrastructure business, where revenue surged 15 percent. The IBM Z mainframe systems were the star act, jumping 48 percent on the back of a hardware refresh cycle and rising demand for AI-capable infrastructure. The segment overall grew 12 percent, providing the bulk of the quarter’s momentum.
Software, by contrast, grew at a more modest 8 percent, with annual recurring revenue reaching $24.6 billion. While respectable, the pace fell short of investor hopes, particularly given the lofty expectations surrounding hybrid cloud and the Watsonx AI platform. Watsonx did cross the $1.5 billion revenue threshold and grew more than 40 percent, but the broader software story left analysts wanting more evidence that artificial intelligence is translating into materially faster top-line growth.
The consulting business proved the weakest link, expanding just 1 percent — a clear signal that corporate clients are tightening their belts on IT spending.
Should investors sell immediately? Or is it worth buying IBM?
Conservative Guidance Fans Flames
CEO Arvind Krishna did little to calm frayed nerves. Despite the strong start, management left the full-year forecast unchanged: revenue growth above 5 percent and free cash flow improvement of roughly $1 billion. Krishna cited the early stage of the fiscal year as justification for the caution, but many investors interpreted the restraint as a hedge against an uncertain macroeconomic backdrop.
The skepticism fits a broader pattern across the technology sector. Markets are increasingly questioning how quickly fat AI order books translate into hard revenue. IBM’s finance chief noted that generative AI now accounts for roughly 30 percent of the company’s order backlog — a figure that raises the stakes for converting those commitments into recognized sales.
Dividend Growth Continues
On the shareholder return front, IBM maintained its long-standing trajectory. The quarterly dividend will rise by one cent to $1.69 per share, marking the 31st consecutive year of increases. The next payment is scheduled for June 10, 2026, with the current annual yield hovering around 2.9 percent.
Institutional positioning tells a mixed story. Munich Re slashed its IBM stake by 63.6 percent, while Generali Investments boosted its position by 26.9 percent. The average analyst rating stands at “Moderate Buy” with a price target of $300.25 — a level the stock last touched in autumn 2025.
The technical picture offers little comfort. The shares now trade more than 17 percent below their 200-day moving average, a bearish signal that suggests the downward trend of recent months may persist unless the company can accelerate software revenue conversion. IBM faces a clear operational imperative: turn that AI backlog into billed revenue, and fast.
Ad
IBM Stock: Buy or Sell?! New IBM Analysis from April 25 delivers the answer:
The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 25.
IBM: Buy or sell? Read more here...
